Below you will find a collection of articles from Hematology, the ASH Education Program, written by experts in the field about risk factors, preventative measures, and treatments for thrombosis. Information about blood clots and blood clotting in pregnancy is also available on this Web site. Additionally, a number of links to organizations that inform and support patients with clotting disorders and their families are available.

Anticoagulants (Blood Thinners)

• Advances in Antiplatelet Therapy (2011)  
• The Clinical Relevance of Response Variability to Antiplatelet Therapy (2011) 
• Duration of Anticoagulation: Applying the Guidelines and Beyond (2010) 
• Warfarin Versus New Agents: Interpreting the Data (2010) 
• Antiplatelet Agents (2009) 
• New Anticoagulants in Children (2008) 
• Warfarin: An Historical Perspective (2008) 
• New Issues in Oral Anticoagulants (2008) 
• Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists (2008) 
• What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin? (2008) 

Arterial and Venous Thrombosis

• Advances in Antiplatelet Therapy (2011) 
• Endovascular Procedures in the Management of DVT (2011) 
• How I Diagnose and Manage HIT (2011) 
• Is Thrombophilia Testing Useful? (2011) 
• The Clinical Relevance of Response Variability to Antiplatelet Therapy (2011) 
• The Role of Platelets in Atherothrombosis (2011) 
• Too Much of a Good Thing at the Site of Tissue Injury: The Instructive Example of the Complement System Predisposing to Thrombotic Microangiopathy (2011) 
• Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants (2010) 
• Evidence-Based Mini Review: Should All Patients with Idiopathic Venous Thromboembolic Events Be Screened Extensively for Occult Malignancy? (2010) 
• Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting (2010) 
• Evidence Base for the Management of Venous Thromboembolism in Pregnancy (2010) 
• The Post-Thrombotic Syndrome (2010) 
• ASH Evidence-Based Guidelines: Statins in the Prevention of Venous Thromboembolism (2009) 
• Pathogenesis of Thrombosis (2009) 
• Risk of Future Arterial Cardiovascular Events in Patients With Idiopathic Venous Thromboembolism (2009) 
• Thrombocytosis and Thrombosis (2007) 
• Thrombophilia: Common Questions on Laboratory Assessment and Management (2007) 
• The Antiphospholipid Syndrome (2007) 

Thrombosis in Children

• Pediatric Thrombophilia and Thrombosis: An Historical Perspective (2008) 
• Thrombophilia in Children: Who to Test, How, When, and Why? (2008) 
• Thrombophilia States and Markers of Coagulation Activiation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence (2008) 
• New Anticoagulants in Children (2008) 

General

• Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting (2010) 
• Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia (2008) 
• Double Hazard of Thrombophilia and Bleeding in Leukemia (2007) 
• Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies (2007) 
• Bleeding and Thrombosis Risks in Plasma Cell Dyscrasias (2007) 

back to top